North America Coagulation Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von Willebrand\'s Disease, and Others), Type [Clinical Laboratory Analyzers (Controls & Calibrators, Assays & Reagents, Instruments/Systems, Coagulation Factors, and Others) and Point-of-Care Testing Analyzers], Offering [Diagnosis (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimmer Testing, Platelets Function Testing, and Others) and Treatment (Anti-Fibrinolytic Drugs, Birth Control Pills, Desmopressin & Immunosuppressive Medicines, Vitamin K Supplements, Blood Thinners, Thrombin Inhibitors or Thrombolytics, Replacement Therapy, Catheter-Assisted Thrombus Removal, and Others)], Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Others), and End User (Clinical Laboratories, Hospitals, and Others)

No. of Pages: 102    |    Report Code: BMIRE00029854    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Coagulation Market

Table of Content

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Coagulation Market - Key Industry Dynamics

4.1 Key Market Drivers:

4.1.1 Increasing Prevalence of Blood Disorders

4.1.2 Rising Prevalence of Cardiovascular Diseases

4.2 Market Restraints

4.2.1 High Costs Associated with Coagulation Analyzers

4.3 Market Opportunities

4.3.1 Growing Organic and Inorganic Strategies by Key Market Players

4.4 Future Trends

4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers

4.5 Impact Analysis

5. Coagulation Market - North America Market Analysis

5.1 North America Coagulation Market Revenue (US$ million), 2022 - 2030

6. North America Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

6.1 Overview

6.2 North America Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)

6.3 Vitamin K Deficiency

6.3.1 Overview

6.3.2 Vitamin K Deficiency: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Liver Disease

6.4.1 Overview

6.4.2 Liver Disease: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism

6.5.1 Overview

6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Development of Circulating Anticoagulant

6.6.1 Overview

6.6.2 Development of Circulating Anticoagulant: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

6.7 Hemophilia

6.7.1 Overview

6.7.2 Hemophilia: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

6.8 Von Willebrand's Disease

6.8.1 Overview

6.8.2 Von Willebrand's Disease: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

6.9 Others

6.9.1 Overview

6.9.2 Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Coagulation Market - Revenue and Forecast to 2030 - by Type

7.1 Overview

7.2 North America Coagulation Market Revenue Share, by Type 2022 & 2030 (%)

7.3 Clinical Laboratory Analyzers

7.3.1 Overview

7.3.2 Clinical Laboratory Analyzers: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

7.3.2.1 North America Coagulation Market, by Clinical Laboratory Analyzers

7.4 Point-of-Care Testing Analyzers

7.4.1 Overview

7.4.2 Point-of-Care Testing Analyzers: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Coagulation Market - Revenue and Forecast to 2030 - by Offering

8.1 Overview

8.2 North America Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)

8.3 Diagnosis

8.3.1 Overview

8.3.2 Diagnosis: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8.3.2.1 North America Coagulation Market, by Diagnosis

8.4 Treatment

8.4.1 Overview

8.4.2 Treatment: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8.4.2.1 North America Coagulation Market, by Treatment

9. North America Coagulation Market - Revenue and Forecast to 2030 - by Technology

9.1 Overview

9.2 North America Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)

9.3 Optical Technology

9.3.1 Overview

9.3.2 Optical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Mechanical Technology

9.4.1 Overview

9.4.2 Mechanical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Electrochemical Technology

9.5.1 Overview

9.5.2 Electrochemical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Coagulation Market - Revenue and Forecast to 2030 - by End User

10.1 Overview

10.2 North America Coagulation Market Revenue Share, by End User 2022 & 2030 (%)

10.3 Clinical Laboratories

10.3.1 Overview

10.3.2 Clinical Laboratories: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Hospitals

10.4.1 Overview

10.4.2 Hospitals: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10.5 Others

10.5.1 Overview

10.5.2 Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Coagulation Market - Country Analysis

11.1 North America Coagulation Market, Revenue and Forecast to 2030

11.1.1.1 North America Coagulation Market, by Country

11.1.1.2 US

11.1.1.2.1 Overview

11.1.1.2.2 US Coagulation Market Revenue and Forecast to 2030 (US$ million)

11.1.1.2.3 US Coagulation Market, by Disease Indication

11.1.1.2.4 US Coagulation Market, by Type

11.1.1.2.4.1 US Coagulation Market, by Clinical Laboratory Analyzers

11.1.1.2.5 US Coagulation Market, by Offering

11.1.1.2.5.1 US Coagulation Market, by Diagnosis

11.1.1.2.5.2 US Coagulation Market, by Treatment

11.1.1.2.6 US Coagulation Market, by Technology

11.1.1.2.7 US Coagulation Market, by End User

11.1.1.3 Canada

11.1.1.3.1 Overview

11.1.1.3.2 Canada Coagulation Market Revenue and Forecast to 2030 (US$ million)

11.1.1.3.3 Canada Coagulation Market, by Disease Indication

11.1.1.3.4 Canada Coagulation Market, by Type

11.1.1.3.4.1 Canada Coagulation Market, by Clinical Laboratory Analyzers

11.1.1.3.5 Canada Coagulation Market, by Offering

11.1.1.3.5.1 Canada Coagulation Market, by Diagnosis

11.1.1.3.5.2 Canada Coagulation Market, by Treatment

11.1.1.3.6 Canada Coagulation Market, by Technology

11.1.1.3.7 Canada Coagulation Market, by End User

11.1.1.4 Mexico

11.1.1.4.1 Overview

11.1.1.4.2 Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million)

11.1.1.4.3 Mexico Coagulation Market, by Disease Indication

11.1.1.4.4 Mexico Coagulation Market, by Type

11.1.1.4.4.1 Mexico Coagulation Market, by Clinical Laboratory Analyzers

11.1.1.4.5 Mexico Coagulation Market, by Offering

11.1.1.4.5.1 Mexico Coagulation Market, by Diagnosis

11.1.1.4.5.2 US Coagulation Market, by Treatment

11.1.1.4.6 Mexico Coagulation Market, by Technology

11.1.1.4.7 Mexico Coagulation Market, by End User

12. Coagulation Market-Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Coagulation Market

12.3 Inorganic Growth Strategies

12.3.1 Overview

12.4 Organic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 Siemens Healthineers AG

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Diagnostica Stago, Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 ImproGen Diagnostik Kimya San. & Tic. Ltd.ti.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Sysmex Corp

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Helena Laboratories Corporation

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 F. Hoffmann-La Roche Ltd

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Genrui Biotech Co., Ltd.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Transasia Bio-Medicals Ltd

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Horiba Ltd.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

 

 

 

List of Tables

Table 1. North America Coagulation Market Segmentation

Table 2. North America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers

Table 3. North America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis

Table 4. North America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment

Table 5. Optical Technologies and Their Applications

Table 6. Mechanical Technologies and Their Applications

Table 7. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication

Table 8. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type

Table 9. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers

Table 10. US Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering

Table 11. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis

Table 12. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment

Table 13. US Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology

Table 14. US Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User

Table 15. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication

Table 16. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type

Table 17. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers

Table 18. Canada Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering

Table 19. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis

Table 20. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment

Table 21. Canada Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology

Table 22. Canada Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User

Table 23. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication

Table 24. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type

Table 25. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers

Table 26. Mexico Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering

Table 27. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis

Table 28. US Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment

Table 29. Mexico Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology

Table 30. Mexico Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User

Table 31. Recent Inorganic Growth Strategies in the Coagulation Market

Table 32. Recent Organic Growth Strategies in the Coagulation Market

Table 33. Glossary of Terms, Coagulation Market

 

List of Figures

Figure 1. North America Coagulation Market Segmentation, By Country

Figure 2. North America Coagulation Market - Key Industry Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. North America Coagulation Market Revenue (US$ million), 2020 - 2030

Figure 5. North America Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)

Figure 6. Vitamin K Deficiency: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Liver Disease: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Disseminated Intravascular Coagulation and Pulmonary Embolism: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Development of Circulating Anticoagulant: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Hemophilia: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Von Willebrand's Disease: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. North America Coagulation Market Revenue Share, by Type 2022 & 2030 (%)

Figure 14. Clinical Laboratory Analyzers: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Point-of-Care Testing Analyzers: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. North America Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)

Figure 17. Diagnosis: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Treatment: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. North America Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)

Figure 20. Optical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Mechanical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Electrochemical Technology: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. North America Coagulation Market Revenue Share, by End User 2022 & 2030 (%)

Figure 25. Clinical Laboratories: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Hospitals: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Others: North America Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. North America Coagulation Market, 2022 (US$)(million)

Figure 29. North America Coagulation Market, By Key Countries, 2022 and 2030 (%)

Figure 30. US Coagulation Market Revenue and Forecast to 2030 (US$ million)

Figure 31. Canada Coagulation Market Revenue and Forecast to 2030 (US$ million)

Figure 32. Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million)

Figure 33. Growth Strategies in the Coagulation Market

The List of Companies - North America Coagulation Market

1. Diagnostica Stago, Inc

 

2. F. Hoffmann-La Roche Ltd

3. Genrui Biotech Co., Ltd

4. Helena Laboratories Corporation

5. Horiba Ltd.

6. ImproGen Diagnostik Kimya San. & Tic. Ltd. ?ti

7. Siemens Healthineers AG

8. Sysmex Corp

9. Transasia Bio-Medicals Ltd